Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Duloxetine 60 to 120 mg Versus Placebo in the Treatment of Patients With Osteoarthritis Knee Pain

NCT00408421 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00408421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00408421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Duloxetine 60 to 120 mg Versus Placebo in the Treatment of Patients With Osteoarthritis Knee Pain
Lead sponsor
Eli Lilly and Company
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2006
Completion date
October 31, 2007
Enrollment
231 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis knee pain